203 related articles for article (PubMed ID: 30846539)
1. Evidence for a multimodal effect of riluzole in patients with ALS?
de Jongh AD; van Eijk RPA; van den Berg LH
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1183-1184. PubMed ID: 30846539
[No Abstract] [Full Text] [Related]
2. Riluzole treatment in advanced ALS.
Borasio GD
J Neurol; 2002 May; 249(5):505-6. PubMed ID: 12021937
[No Abstract] [Full Text] [Related]
3. Riluzole for the treatment of amyotrophic lateral sclerosis.
Saitoh Y; Takahashi Y
Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
[TBL] [Abstract][Full Text] [Related]
4. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
Noto Y; Shibuya K; Vucic S; Kiernan MC
Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
6. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
Cheah BC; Vucic S; Krishnan AV; Kiernan MC
Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
[TBL] [Abstract][Full Text] [Related]
7. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
[TBL] [Abstract][Full Text] [Related]
8. Management of amyotrophic lateral sclerosis with riluzole.
Neatherlin JS
J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
[TBL] [Abstract][Full Text] [Related]
9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
[TBL] [Abstract][Full Text] [Related]
10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
[TBL] [Abstract][Full Text] [Related]
11. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
12. Amyotrophic lateral sclerosis: practical aspects of care.
Krivickas LS; Carter GT
J Spinal Cord Med; 2002; 25(4):274-6. PubMed ID: 12482168
[No Abstract] [Full Text] [Related]
13. Therapies in amyotrophic lateral sclerosis-beyond riluzole.
Morrison KE
Curr Opin Pharmacol; 2002 Jun; 2(3):302-9. PubMed ID: 12020475
[TBL] [Abstract][Full Text] [Related]
14. Early symptom progression rate is related to ALS outcome: a prospective population-based study.
Turner M; Al-Chalabi A
Neurology; 2002 Dec; 59(12):2012-3; author reply 2013. PubMed ID: 12499513
[No Abstract] [Full Text] [Related]
15. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
Obrenovitch TP
Trends Pharmacol Sci; 1998 Jan; 19(1):9-11. PubMed ID: 9509893
[No Abstract] [Full Text] [Related]
17. Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme.
Meyer T; Kettemann D; Maier A; Grehl T; Weyen U; Grosskreutz J; Steinbach R; Norden J; George A; Hermann A; Guenther R; Petri S; Schreiber-Katz O; Dorst J; Ludolph AC; Walter B; Münch C; Spittel S
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):783-785. PubMed ID: 32317400
[No Abstract] [Full Text] [Related]
18. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.
Jaiswal MK
Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
[TBL] [Abstract][Full Text] [Related]
20. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2001; (4):CD001447. PubMed ID: 11687111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
